FDA Inspection 1046306 — HCSC-Blood Center

HCSC-Blood Center — FEI 2573135

The FDA completed an inspection of HCSC-Blood Center on Mar 15, 2018 in Bethlehem, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 15, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bethlehem, PA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.